Silvergate Pharmaceuticals
Total Raised
$26.15MInvestors Count
2Deal Terms
2Funding, Valuation & Revenue
5 Fundings
Silvergate Pharmaceuticals has raised $26.15M over 5 rounds.
Silvergate Pharmaceuticals's latest funding round was a Acquired for on June 12, 2019.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
6/12/2019 | Acquired | 1 | ||||
10/18/2016 | Option/Warrant | |||||
10/14/2015 | Debt | |||||
9/12/2014 | Series A - II | |||||
6/14/2013 | Series A |
Date | 6/12/2019 | 10/18/2016 | 10/14/2015 | 9/12/2014 | 6/14/2013 |
|---|---|---|---|---|---|
Round | Acquired | Option/Warrant | Debt | Series A - II | Series A |
Amount | |||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
Silvergate Pharmaceuticals Deal Terms
2 Deal Terms
Silvergate Pharmaceuticals's deal structure is available for 2 funding rounds, including their Series A - II from September 12, 2014.
Round | Series A - II | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series A - II | |||||||||||||||
Series A |
Silvergate Pharmaceuticals Investors
2 Investors
Silvergate Pharmaceuticals has 2 investors. Azurity Pharmaceuticals invested in Silvergate Pharmaceuticals's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
6/12/2019 | 6/12/2019 | 1 Acquired | Corporation | Massachusetts | ||
Private Equity | Washington |
First funding | 6/12/2019 | |
|---|---|---|
Last Funding | 6/12/2019 | |
Investor | ||
Rounds | 1 Acquired | |
Board Seats | ||
Type | Corporation | Private Equity |
Location | Massachusetts | Washington |
Loading...